← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
ROPER TECHNOLOGIES INC: Revenue grew 12.3% to $7.902B from $7.039B. Net income declined 0.8% to $1.536B from $1.549B. Free cash flow grew 7.1% to $2.493B from $2.327B. Operating margin contracted 8 bps to 28.29%. ROPER TECHNOLOGIES INC's annual comparison also shows stock compensation grew faster than revenue; inventory grew faster than revenue.
The read at a glance✓ Audited against SEC data
- Growth — Revenue grew 12.3%OK
- Profitability — Net income declined 0.8% to $1.536B from $1.549BWatch
- Cash flow — Free cash flow grew 7.1% to $2.493B from $2.327BOK
- Margins — Operating margin contracted 8 bps to 28.29%Watch
- Accounting — No overriding statistical warningNote
- Insiders — 3 purchases and 4 salesOK
Business
Competition Generally, our products and solutions face significant competition, although in certain niche markets there are a limited number of competitors.
Where the revenue comes from
Fiscal 2025, as ROPER TECHNOLOGIES INC reports it. History and quarterly detail are in the app.
- Application Software$4.5B
- Technology Enabled Products$1.8B
- Network Software$1.6B
Latest filings
- 8-K · Company announcement2026-08-10
- 10-Q · Quarterly report2026-07-31
- 8-K · Company announcement2026-07-23
- 8-K · Company announcement2026-05-19
- 10-Q · Quarterly report2026-05-01
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about ROPER TECHNOLOGIES INC, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.